UnitedHealth will spend nearly $1.5 billion on AI in 2026 and expects to claw back $3 billion within 18 months. Chief Digital and Technology Officer Sandeep Dadlani laid out the math on the Q1 2026 earnings call.
A third of the budget goes to Optum Insight’s AI-first product rebuild. The other two-thirds funds internal operations: member experience, clinical workflows, admin, HR, finance, marketing. The return target is 2-to-1 in the “next few years,” with most programs paying back in 12 to 18 months.
Two numbers tell the story. Optum Real, UnitedHealth’s AI-first claims and reimbursement platform, will process 2.5 billion transactions by year end, up from 500 million now. Avery, the generative AI chatbot, rolls out to more than 20 million UHC members by the same deadline.
The compliance pressure isn’t trailing the capex. AI-driven claims processing is already on DOJ and state AG radar after class action suits against UHC’s nH Predict algorithm, and CMS has signaled tighter rules on prior authorization automation for Medicare Advantage. Scaling Optum Real to 2.5 billion transactions means scaling exposure to the same regulatory questions.
Q1 earnings beat estimates. The stock jumped. It’s the turnaround plan now.